MRTX1133 MECHANISM OF ACTION CAN BE FUN FOR ANYONE

The identification of KRASG12C inhibitors has reignited fascination in targeting RAS proteins. This work describes the discovery of the KRASG12D-unique inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively focusing on this oncogenic variant.In a very trial involving 38 patients with State-of-the-art pancreatic cancer, as a